0.017241 0.000000 0.000000 0.000000 0.011655 0.000000 0.000000 0.000000 0.021505 0.00000 0.00000 0.00000 Backbro, K. Unge, T. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 90.00 90.00 58.000 85.800 46.500 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C32 H34 N2 O6 S 574.687 2,7-DIBENZYL-1,1-DIOXO-3,6-BIS-PHENOXYMETHYL-[1,2,7]THIADIAZEPANE-4,5-DIOL non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Med.Chem. JMCMAR 0151 0022-2623 40 898 902 10.1021/jm960588d 9083478 Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitor. 1997 10.2210/pdb1ajv/pdb pdb_00001ajv 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 278 1 IMAGE PLATE 1995-05 MARRESEARCH M x-ray 1 0.9 1.0 DW32 LURE 0.9 SYNCHROTRON LURE BEAMLINE DW32 10803.756 HIV-1 PROTEASE 3.4.23.16 2 man polymer 574.687 2,7-DIBENZYL-1,1-DIOXO-3,6-BIS-PHENOXYMETHYL-[1,2,7]THIADIAZEPANE-4,5-DIOL 1 syn non-polymer 18.015 water 75 nat water no no PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPT PVNIIGRNLLTQIGCTLNF PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPT PVNIIGRNLLTQIGCTLNF A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Lentivirus BH10 Escherichia Escherichia coli sample BL21 PROTEASE 11676 Human immunodeficiency virus 1 PROTEASE 469008 Escherichia coli BL21(DE3) BL21 (DE3) PET11C 1 2.8 54.03 VAPOR DIFFUSION 5.5 CRYSTALLIZATION WAS PERFORMED BY VAPOR DIFFUSION. PROTEASE (2 MG/ML) AND INHIBITOR (40 MM IN DMSO) WAS MIXED IN A RATIO OF 1:1 AND SUBJECTED TO COCRYSTALLIZATION. DROPS CONSISTING OF 5 MICROLITERS OF THE PROTEASE-INHIBITOR MIXTURE PLUS 5 MICROLITERS OF THE CRYSTALLIZATION BUFFER (50 MM MES PH 5.5, 0.4 M NACL AND 0.02% (W/V) NAN3) WERE EQUILIBRATED AGAINST THE SAME BUFFER AT 4 DEGREES C., vapor diffusion, temperature 277K 277 database_2 pdbx_database_status pdbx_initial_refinement_model struct_site repository Initial release Version format compliance Version format compliance Database references Derived calculations Other Refinement description 1 0 1997-08-20 1 1 2008-03-24 1 2 2011-07-13 1 3 2023-08-02 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id Y BNL 1997-05-11 REL REL NMB 2,7-DIBENZYL-1,1-DIOXO-3,6-BIS-PHENOXYMETHYL-[1,2,7]THIADIAZEPANE-4,5-DIOL HOH water 4PHV PDB ENTRY 4PHV PDB experimental model NMB 501 2 NMB NMB 501 A HOH 302 3 HOH HOH 302 A HOH 303 3 HOH HOH 303 A HOH 307 3 HOH HOH 307 A HOH 309 3 HOH HOH 309 A HOH 312 3 HOH HOH 312 A HOH 313 3 HOH HOH 313 A HOH 317 3 HOH HOH 317 A HOH 318 3 HOH HOH 318 A HOH 321 3 HOH HOH 321 A HOH 324 3 HOH HOH 324 A HOH 325 3 HOH HOH 325 A HOH 328 3 HOH HOH 328 A HOH 331 3 HOH HOH 331 A HOH 334 3 HOH HOH 334 A HOH 339 3 HOH HOH 339 A HOH 341 3 HOH HOH 341 A HOH 342 3 HOH HOH 342 A HOH 343 3 HOH HOH 343 A HOH 344 3 HOH HOH 344 A HOH 345 3 HOH HOH 345 A HOH 347 3 HOH HOH 347 A HOH 348 3 HOH HOH 348 A HOH 349 3 HOH HOH 349 A HOH 352 3 HOH HOH 352 A HOH 359 3 HOH HOH 359 A HOH 361 3 HOH HOH 361 A HOH 363 3 HOH HOH 363 A HOH 301 3 HOH HOH 301 B HOH 304 3 HOH HOH 304 B HOH 305 3 HOH HOH 305 B HOH 306 3 HOH HOH 306 B HOH 308 3 HOH HOH 308 B HOH 310 3 HOH HOH 310 B HOH 311 3 HOH HOH 311 B HOH 314 3 HOH HOH 314 B HOH 315 3 HOH HOH 315 B HOH 316 3 HOH HOH 316 B HOH 319 3 HOH HOH 319 B HOH 320 3 HOH HOH 320 B HOH 322 3 HOH HOH 322 B HOH 323 3 HOH HOH 323 B HOH 326 3 HOH HOH 326 B HOH 327 3 HOH HOH 327 B HOH 329 3 HOH HOH 329 B HOH 330 3 HOH HOH 330 B HOH 332 3 HOH HOH 332 B HOH 333 3 HOH HOH 333 B HOH 335 3 HOH HOH 335 B HOH 336 3 HOH HOH 336 B HOH 337 3 HOH HOH 337 B HOH 338 3 HOH HOH 338 B HOH 340 3 HOH HOH 340 B HOH 346 3 HOH HOH 346 B HOH 350 3 HOH HOH 350 B HOH 351 3 HOH HOH 351 B HOH 353 3 HOH HOH 353 B HOH 354 3 HOH HOH 354 B HOH 355 3 HOH HOH 355 B HOH 356 3 HOH HOH 356 B HOH 357 3 HOH HOH 357 B HOH 358 3 HOH HOH 358 B HOH 360 3 HOH HOH 360 B HOH 362 3 HOH HOH 362 B HOH 364 3 HOH HOH 364 B HOH 365 3 HOH HOH 365 B HOH 366 3 HOH HOH 366 B HOH 367 3 HOH HOH 367 B HOH 368 3 HOH HOH 368 B HOH 369 3 HOH HOH 369 B HOH 370 3 HOH HOH 370 B HOH 371 3 HOH HOH 371 B HOH 372 3 HOH HOH 372 B HOH 373 3 HOH HOH 373 B HOH 374 3 HOH HOH 374 B HOH 375 3 HOH HOH 375 B PRO 1 n 1 PRO 1 A GLN 2 n 2 GLN 2 A ILE 3 n 3 ILE 3 A THR 4 n 4 THR 4 A LEU 5 n 5 LEU 5 A TRP 6 n 6 TRP 6 A GLN 7 n 7 GLN 7 A ARG 8 n 8 ARG 8 A PRO 9 n 9 PRO 9 A LEU 10 n 10 LEU 10 A VAL 11 n 11 VAL 11 A THR 12 n 12 THR 12 A ILE 13 n 13 ILE 13 A LYS 14 n 14 LYS 14 A ILE 15 n 15 ILE 15 A GLY 16 n 16 GLY 16 A GLY 17 n 17 GLY 17 A GLN 18 n 18 GLN 18 A LEU 19 n 19 LEU 19 A LYS 20 n 20 LYS 20 A GLU 21 n 21 GLU 21 A ALA 22 n 22 ALA 22 A LEU 23 n 23 LEU 23 A LEU 24 n 24 LEU 24 A ASP 25 n 25 ASP 25 A THR 26 n 26 THR 26 A GLY 27 n 27 GLY 27 A ALA 28 n 28 ALA 28 A ASP 29 n 29 ASP 29 A ASP 30 n 30 ASP 30 A THR 31 n 31 THR 31 A VAL 32 n 32 VAL 32 A LEU 33 n 33 LEU 33 A GLU 34 n 34 GLU 34 A GLU 35 n 35 GLU 35 A MET 36 n 36 MET 36 A SER 37 n 37 SER 37 A LEU 38 n 38 LEU 38 A PRO 39 n 39 PRO 39 A GLY 40 n 40 GLY 40 A ARG 41 n 41 ARG 41 A TRP 42 n 42 TRP 42 A LYS 43 n 43 LYS 43 A PRO 44 n 44 PRO 44 A LYS 45 n 45 LYS 45 A MET 46 n 46 MET 46 A ILE 47 n 47 ILE 47 A GLY 48 n 48 GLY 48 A GLY 49 n 49 GLY 49 A ILE 50 n 50 ILE 50 A GLY 51 n 51 GLY 51 A GLY 52 n 52 GLY 52 A PHE 53 n 53 PHE 53 A ILE 54 n 54 ILE 54 A LYS 55 n 55 LYS 55 A VAL 56 n 56 VAL 56 A ARG 57 n 57 ARG 57 A GLN 58 n 58 GLN 58 A TYR 59 n 59 TYR 59 A ASP 60 n 60 ASP 60 A GLN 61 n 61 GLN 61 A ILE 62 n 62 ILE 62 A LEU 63 n 63 LEU 63 A ILE 64 n 64 ILE 64 A GLU 65 n 65 GLU 65 A ILE 66 n 66 ILE 66 A CYS 67 n 67 CYS 67 A GLY 68 n 68 GLY 68 A HIS 69 n 69 HIS 69 A LYS 70 n 70 LYS 70 A ALA 71 n 71 ALA 71 A ILE 72 n 72 ILE 72 A GLY 73 n 73 GLY 73 A THR 74 n 74 THR 74 A VAL 75 n 75 VAL 75 A LEU 76 n 76 LEU 76 A VAL 77 n 77 VAL 77 A GLY 78 n 78 GLY 78 A PRO 79 n 79 PRO 79 A THR 80 n 80 THR 80 A PRO 81 n 81 PRO 81 A VAL 82 n 82 VAL 82 A ASN 83 n 83 ASN 83 A ILE 84 n 84 ILE 84 A ILE 85 n 85 ILE 85 A GLY 86 n 86 GLY 86 A ARG 87 n 87 ARG 87 A ASN 88 n 88 ASN 88 A LEU 89 n 89 LEU 89 A LEU 90 n 90 LEU 90 A THR 91 n 91 THR 91 A GLN 92 n 92 GLN 92 A ILE 93 n 93 ILE 93 A GLY 94 n 94 GLY 94 A CYS 95 n 95 CYS 95 A THR 96 n 96 THR 96 A LEU 97 n 97 LEU 97 A ASN 98 n 98 ASN 98 A PHE 99 n 99 PHE 99 A PRO 1 n 1 PRO 1 B GLN 2 n 2 GLN 2 B ILE 3 n 3 ILE 3 B THR 4 n 4 THR 4 B LEU 5 n 5 LEU 5 B TRP 6 n 6 TRP 6 B GLN 7 n 7 GLN 7 B ARG 8 n 8 ARG 8 B PRO 9 n 9 PRO 9 B LEU 10 n 10 LEU 10 B VAL 11 n 11 VAL 11 B THR 12 n 12 THR 12 B ILE 13 n 13 ILE 13 B LYS 14 n 14 LYS 14 B ILE 15 n 15 ILE 15 B GLY 16 n 16 GLY 16 B GLY 17 n 17 GLY 17 B GLN 18 n 18 GLN 18 B LEU 19 n 19 LEU 19 B LYS 20 n 20 LYS 20 B GLU 21 n 21 GLU 21 B ALA 22 n 22 ALA 22 B LEU 23 n 23 LEU 23 B LEU 24 n 24 LEU 24 B ASP 25 n 25 ASP 25 B THR 26 n 26 THR 26 B GLY 27 n 27 GLY 27 B ALA 28 n 28 ALA 28 B ASP 29 n 29 ASP 29 B ASP 30 n 30 ASP 30 B THR 31 n 31 THR 31 B VAL 32 n 32 VAL 32 B LEU 33 n 33 LEU 33 B GLU 34 n 34 GLU 34 B GLU 35 n 35 GLU 35 B MET 36 n 36 MET 36 B SER 37 n 37 SER 37 B LEU 38 n 38 LEU 38 B PRO 39 n 39 PRO 39 B GLY 40 n 40 GLY 40 B ARG 41 n 41 ARG 41 B TRP 42 n 42 TRP 42 B LYS 43 n 43 LYS 43 B PRO 44 n 44 PRO 44 B LYS 45 n 45 LYS 45 B MET 46 n 46 MET 46 B ILE 47 n 47 ILE 47 B GLY 48 n 48 GLY 48 B GLY 49 n 49 GLY 49 B ILE 50 n 50 ILE 50 B GLY 51 n 51 GLY 51 B GLY 52 n 52 GLY 52 B PHE 53 n 53 PHE 53 B ILE 54 n 54 ILE 54 B LYS 55 n 55 LYS 55 B VAL 56 n 56 VAL 56 B ARG 57 n 57 ARG 57 B GLN 58 n 58 GLN 58 B TYR 59 n 59 TYR 59 B ASP 60 n 60 ASP 60 B GLN 61 n 61 GLN 61 B ILE 62 n 62 ILE 62 B LEU 63 n 63 LEU 63 B ILE 64 n 64 ILE 64 B GLU 65 n 65 GLU 65 B ILE 66 n 66 ILE 66 B CYS 67 n 67 CYS 67 B GLY 68 n 68 GLY 68 B HIS 69 n 69 HIS 69 B LYS 70 n 70 LYS 70 B ALA 71 n 71 ALA 71 B ILE 72 n 72 ILE 72 B GLY 73 n 73 GLY 73 B THR 74 n 74 THR 74 B VAL 75 n 75 VAL 75 B LEU 76 n 76 LEU 76 B VAL 77 n 77 VAL 77 B GLY 78 n 78 GLY 78 B PRO 79 n 79 PRO 79 B THR 80 n 80 THR 80 B PRO 81 n 81 PRO 81 B VAL 82 n 82 VAL 82 B ASN 83 n 83 ASN 83 B ILE 84 n 84 ILE 84 B ILE 85 n 85 ILE 85 B GLY 86 n 86 GLY 86 B ARG 87 n 87 ARG 87 B ASN 88 n 88 ASN 88 B LEU 89 n 89 LEU 89 B LEU 90 n 90 LEU 90 B THR 91 n 91 THR 91 B GLN 92 n 92 GLN 92 B ILE 93 n 93 ILE 93 B GLY 94 n 94 GLY 94 B CYS 95 n 95 CYS 95 B THR 96 n 96 THR 96 B LEU 97 n 97 LEU 97 B ASN 98 n 98 ASN 98 B PHE 99 n 99 PHE 99 B author_and_software_defined_assembly PISA 2 dimeric 4870 -32 9100 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O VAL 11 A O VAL 11 A N ALA 22 A N ALA 22 A O LYS 43 A O LYS 43 A N GLN 58 A N GLN 58 A O ARG 57 A O ARG 57 A N VAL 77 A N VAL 77 A O ILE 62 A O ILE 62 A N GLY 73 A N GLY 73 B O GLN 18 B O GLN 18 B N ILE 15 B N ILE 15 B O LYS 14 B O LYS 14 B N GLU 65 B N GLU 65 B O ILE 62 B O ILE 62 B N GLY 73 B N GLY 73 B O LYS 43 B O LYS 43 B N GLN 58 B N GLN 58 B O ARG 57 B O ARG 57 B N VAL 77 B N VAL 77 1 A PRO 79 -73.29 49.22 PARHCSDX.PRO TOPHCSDX.PRO AHA006.PAR AHA006.TOP 17. 0.2470000 0.1870000 0.1870000 2.00 8.00 14846 10. 91.7 RANDOM 1 THROUGHOUT 2.0 MOLECULAR REPLACEMENT PDB ENTRY 4PHV 2.00 8.00 75 1962 41 0 1846 0.010 1.90 25.5 1.32 0.0880000 2.07 1397 10 88.2 2.0 25.0 1AJV 14846 2. 0.0410000 1 91.7 0.0880000 2.0 2.07 80. model building X-PLOR refinement X-PLOR 3.1 data reduction DENZO data scaling SCALEPACK phasing X-PLOR HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006 1 N N 1 N N 2 N N 3 N N 3 N N A ARG 87 A ARG 87 HELX_P A LEU 90 A LEU 90 1 1 4 B ARG 87 B ARG 87 HELX_P B LEU 90 B LEU 90 1 2 4 ASPARTYL PROTEASE PROTEASE, ASPARTYL PROTEASE, NON-PEPTIDE INHIBITOR, DRUG DESIGN, HIV-1 POL_HV1B1 UNP 1 1 P03366 FFREDLAFLQGKAREFSSEQTRANSPTISSEQTRANSPTRRELQVWGRDNNSPSEAGADRQGTVSFNFPQITLWQRPLVT IKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQ IGCTLNFPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRK LVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSINNETPGIRYQYNVLPQGW KGSPAIFQSSMTKILEPFKKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYE LHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEP VHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQKITTESIVIWGKTPKFKLPI QKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIVGAETFYVDGAANRETKLGKAGYVTNKGRQKVVPLTNTT NQKTELQAIYLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVNQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVS AGIRKILFLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVI LVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTSATVKAACWWAGIKQEFGIPYNPQSQGVVES MNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNP LWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 69 167 1AJV 1 99 P03366 A 1 1 99 69 167 1AJV 1 99 P03366 B 1 1 99 2 3 2 4 3 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A LEU 10 A LEU 10 A ILE 15 A ILE 15 A GLN 18 A GLN 18 A LEU 23 A LEU 23 A LYS 43 A LYS 43 A GLY 49 A GLY 49 A GLY 52 A GLY 52 A TYR 59 A TYR 59 A VAL 75 A VAL 75 A GLY 78 A GLY 78 A ILE 62 A ILE 62 A ILE 66 A ILE 66 A HIS 69 A HIS 69 A GLY 73 A GLY 73 B GLN 18 B GLN 18 B LEU 23 B LEU 23 B LEU 10 B LEU 10 B ILE 15 B ILE 15 B ILE 62 B ILE 62 B ILE 66 B ILE 66 B HIS 69 B HIS 69 B GLY 73 B GLY 73 B LYS 43 B LYS 43 B GLY 49 B GLY 49 B GLY 52 B GLY 52 B TYR 59 B TYR 59 B VAL 75 B VAL 75 B VAL 77 B VAL 77 BINDING SITE FOR RESIDUE NMB A 501 A NMB 501 Software 19 A ASP 25 A ASP 25 19 1_555 A GLY 27 A GLY 27 19 1_555 A ALA 28 A ALA 28 19 1_555 A GLY 48 A GLY 48 19 1_555 A GLY 49 A GLY 49 19 1_555 A ILE 50 A ILE 50 19 1_555 A VAL 82 A VAL 82 19 1_555 B LEU 23 B LEU 23 19 1_555 B ASP 25 B ASP 25 19 1_555 B GLY 27 B GLY 27 19 1_555 B ALA 28 B ALA 28 19 1_555 B ASP 29 B ASP 29 19 1_555 B ASP 30 B ASP 30 19 1_555 B VAL 32 B VAL 32 19 1_555 B GLY 48 B GLY 48 19 1_555 B GLY 49 B GLY 49 19 1_555 B ILE 50 B ILE 50 19 1_555 B PRO 81 B PRO 81 19 1_555 B HOH 301 E HOH 19 1_555 18 P 21 21 2